Concepedia

Shivinder Jolly

SJ

Statistics

Publications

6

Citations

1K

H-Index

6

Active since

2008

Affiliations

University Medical Center Groningen(Current)

Renal Associates P. A.

University of Copenhagen

Harvard University

University of Glasgow

Shivinder Jolly is an author at University Medical Center Groningen specializing in medicine, renal disease, and chronic kidney disease.

Publications per year

2008–2025

6

Publications

6

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 612 citations · Full text

, , +10

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 227 citations · Full text

, , +14

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cinacalcet HCl in Participants With CKD Not Receiving Dialysis

Francesco Locatelli, H. E. Abboud, Ángel L.M. de Francisco et al. · American Journal of Kidney Diseases · 2008 · 124 citations

, , +10

The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease

Kirsten L. Johansen, Alexander R. Cobitz, Ajay Singh et al. · Kidney International · 2023 · 38 citations · Full text

, , +16

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Rajiv Agarwal, Jennifer B. Green, Hiddo J.L. Heerspink et al. · Nephrology Dialysis Transplantation · 2025 · 21 citations · Full text

, , +17

1–5 of 6